As filed with the Securities and Exchange Commission on March 2, 2018. Registration No. 333‑ SECURITIES...
As filed with the Securities and Exchange Commission on March 2, 2018. Registration No. 333‑ SECURITIES AND...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM...
Interim Analysis from EG-1962 Phase 3 NEWTON 2 Study in Aneurysmal Subarachnoid Hemorrhage Expected by the...
BERKELEY HEIGHTS, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
BERKELEY HEIGHTS, N.J., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a...
CUSIP NO. 279870109 &n...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.